Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt: Incidence and Risk Factors

O. Riggio, M. Merli, G. Pedretti, R. Servi, P. Meddi, R. Lionetti, P. Rossi, M. Bezzi, F. Salvatori, U. Ugolotti, F. Fiaccadori, L. Capocaccia

Research output: Contribution to journalArticle

Abstract

Forty-seven consecutive patients were prospectively evaluated to study the incidence of hepatic encephalopathy as well as modifications in the PSE index after TIPS. Various clinical, laboratory, and angiographic parameters were also recorded to identify risk factors for the development of post-TIPS hepatic encephalopathy (HE). Mean follow-up was 17 ± 7 months. During follow-up, six patients died and one underwent transplantation. All other patients were followed for at least a year. Fifteen patients (32%) experienced 20 acute episodes of precipitated HE (hospitalization was necessary in 10 instances), and five patients (11%) presented a continuous alteration in mental status with frequent spontaneous exacerbation during follow-up. Both precipitated and spontaneous HE occurred more frequently during the first three months of follow-up. Moreover the PSE index was significantly worse than basal values one month after TIPS, thereafter returning to near basal values. HE was successfully treated in all patients but one who required a reduction in the stent/shunt diameter. Increasing age (>65 years) and low portacaval gradient (10 mm Hg to avoid an unacceptable rate of HE after TIPS.

Original languageEnglish
Pages (from-to)578-584
Number of pages7
JournalDigestive Diseases and Sciences
Volume41
Issue number3
Publication statusPublished - 1996

Fingerprint

Transjugular Intrahepatic Portasystemic Shunt
Hepatic Encephalopathy
Incidence
Stents
Hospitalization
Cohort Studies
Transplantation

Keywords

  • Hepatic encephalopathy
  • Transjugular intrahepatic portosystemic shunt

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Riggio, O., Merli, M., Pedretti, G., Servi, R., Meddi, P., Lionetti, R., ... Capocaccia, L. (1996). Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt: Incidence and Risk Factors. Digestive Diseases and Sciences, 41(3), 578-584.

Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt : Incidence and Risk Factors. / Riggio, O.; Merli, M.; Pedretti, G.; Servi, R.; Meddi, P.; Lionetti, R.; Rossi, P.; Bezzi, M.; Salvatori, F.; Ugolotti, U.; Fiaccadori, F.; Capocaccia, L.

In: Digestive Diseases and Sciences, Vol. 41, No. 3, 1996, p. 578-584.

Research output: Contribution to journalArticle

Riggio, O, Merli, M, Pedretti, G, Servi, R, Meddi, P, Lionetti, R, Rossi, P, Bezzi, M, Salvatori, F, Ugolotti, U, Fiaccadori, F & Capocaccia, L 1996, 'Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt: Incidence and Risk Factors', Digestive Diseases and Sciences, vol. 41, no. 3, pp. 578-584.
Riggio, O. ; Merli, M. ; Pedretti, G. ; Servi, R. ; Meddi, P. ; Lionetti, R. ; Rossi, P. ; Bezzi, M. ; Salvatori, F. ; Ugolotti, U. ; Fiaccadori, F. ; Capocaccia, L. / Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt : Incidence and Risk Factors. In: Digestive Diseases and Sciences. 1996 ; Vol. 41, No. 3. pp. 578-584.
@article{b697c6b591b34de4b04930d34a9c4a93,
title = "Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt: Incidence and Risk Factors",
abstract = "Forty-seven consecutive patients were prospectively evaluated to study the incidence of hepatic encephalopathy as well as modifications in the PSE index after TIPS. Various clinical, laboratory, and angiographic parameters were also recorded to identify risk factors for the development of post-TIPS hepatic encephalopathy (HE). Mean follow-up was 17 ± 7 months. During follow-up, six patients died and one underwent transplantation. All other patients were followed for at least a year. Fifteen patients (32{\%}) experienced 20 acute episodes of precipitated HE (hospitalization was necessary in 10 instances), and five patients (11{\%}) presented a continuous alteration in mental status with frequent spontaneous exacerbation during follow-up. Both precipitated and spontaneous HE occurred more frequently during the first three months of follow-up. Moreover the PSE index was significantly worse than basal values one month after TIPS, thereafter returning to near basal values. HE was successfully treated in all patients but one who required a reduction in the stent/shunt diameter. Increasing age (>65 years) and low portacaval gradient (10 mm Hg to avoid an unacceptable rate of HE after TIPS.",
keywords = "Hepatic encephalopathy, Transjugular intrahepatic portosystemic shunt",
author = "O. Riggio and M. Merli and G. Pedretti and R. Servi and P. Meddi and R. Lionetti and P. Rossi and M. Bezzi and F. Salvatori and U. Ugolotti and F. Fiaccadori and L. Capocaccia",
year = "1996",
language = "English",
volume = "41",
pages = "578--584",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt

T2 - Incidence and Risk Factors

AU - Riggio, O.

AU - Merli, M.

AU - Pedretti, G.

AU - Servi, R.

AU - Meddi, P.

AU - Lionetti, R.

AU - Rossi, P.

AU - Bezzi, M.

AU - Salvatori, F.

AU - Ugolotti, U.

AU - Fiaccadori, F.

AU - Capocaccia, L.

PY - 1996

Y1 - 1996

N2 - Forty-seven consecutive patients were prospectively evaluated to study the incidence of hepatic encephalopathy as well as modifications in the PSE index after TIPS. Various clinical, laboratory, and angiographic parameters were also recorded to identify risk factors for the development of post-TIPS hepatic encephalopathy (HE). Mean follow-up was 17 ± 7 months. During follow-up, six patients died and one underwent transplantation. All other patients were followed for at least a year. Fifteen patients (32%) experienced 20 acute episodes of precipitated HE (hospitalization was necessary in 10 instances), and five patients (11%) presented a continuous alteration in mental status with frequent spontaneous exacerbation during follow-up. Both precipitated and spontaneous HE occurred more frequently during the first three months of follow-up. Moreover the PSE index was significantly worse than basal values one month after TIPS, thereafter returning to near basal values. HE was successfully treated in all patients but one who required a reduction in the stent/shunt diameter. Increasing age (>65 years) and low portacaval gradient (10 mm Hg to avoid an unacceptable rate of HE after TIPS.

AB - Forty-seven consecutive patients were prospectively evaluated to study the incidence of hepatic encephalopathy as well as modifications in the PSE index after TIPS. Various clinical, laboratory, and angiographic parameters were also recorded to identify risk factors for the development of post-TIPS hepatic encephalopathy (HE). Mean follow-up was 17 ± 7 months. During follow-up, six patients died and one underwent transplantation. All other patients were followed for at least a year. Fifteen patients (32%) experienced 20 acute episodes of precipitated HE (hospitalization was necessary in 10 instances), and five patients (11%) presented a continuous alteration in mental status with frequent spontaneous exacerbation during follow-up. Both precipitated and spontaneous HE occurred more frequently during the first three months of follow-up. Moreover the PSE index was significantly worse than basal values one month after TIPS, thereafter returning to near basal values. HE was successfully treated in all patients but one who required a reduction in the stent/shunt diameter. Increasing age (>65 years) and low portacaval gradient (10 mm Hg to avoid an unacceptable rate of HE after TIPS.

KW - Hepatic encephalopathy

KW - Transjugular intrahepatic portosystemic shunt

UR - http://www.scopus.com/inward/record.url?scp=0029872090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029872090&partnerID=8YFLogxK

M3 - Article

C2 - 8617139

AN - SCOPUS:0029872090

VL - 41

SP - 578

EP - 584

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 3

ER -